195 related articles for article (PubMed ID: 21963785)
1. Intragenic deletion as a novel type of mutation in Wolman disease.
Lee TM; Welsh M; Benhamed S; Chung WK
Mol Genet Metab; 2011 Dec; 104(4):703-5. PubMed ID: 21963785
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.
Fasano T; Pisciotta L; Bocchi L; Guardamagna O; Assandro P; Rabacchi C; Zanoni P; Filocamo M; Bertolini S; Calandra S
Mol Genet Metab; 2012 Mar; 105(3):450-6. PubMed ID: 22227072
[TBL] [Abstract][Full Text] [Related]
3. Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.
Lohse P; Maas S; Sewell AC; van Diggelen OP ; Seidel D
J Lipid Res; 1999 Feb; 40(2):221-8. PubMed ID: 9925650
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.
Porto AF
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():125-32. PubMed ID: 25345094
[TBL] [Abstract][Full Text] [Related]
5. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.
Carter A; Brackley SM; Gao J; Mann JP
J Hepatol; 2019 Jan; 70(1):142-150. PubMed ID: 30315827
[TBL] [Abstract][Full Text] [Related]
6. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
Aslanidis C; Ries S; Fehringer P; Büchler C; Klima H; Schmitz G
Genomics; 1996 Apr; 33(1):85-93. PubMed ID: 8617513
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
[TBL] [Abstract][Full Text] [Related]
8. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
Pullinger CR; Stock EO; Movsesyan I; Malloy MJ; Frost PH; Tripuraneni R; Quinn AG; Ishida BY; Schaefer EJ; Asztalos BF; Kane JP
J Clin Lipidol; 2015; 9(5):716-26.e1. PubMed ID: 26350820
[TBL] [Abstract][Full Text] [Related]
9. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.
Pisciotta L; Tozzi G; Travaglini L; Taurisano R; Lucchi T; Indolfi G; Papadia F; Di Rocco M; D'Antiga L; Crock P; Vora K; Nightingale S; Michelakakis H; Garoufi A; Lykopoulou L; Bertolini S; Calandra S
Atherosclerosis; 2017 Oct; 265():124-132. PubMed ID: 28881270
[TBL] [Abstract][Full Text] [Related]
10. The novel synonymous variant in LIPA gene affects splicing and causes lysosomal acid lipase deficiency.
Bychkov IO; Kamenets EA; Filatova AY; Skoblov MY; Mikhaylova SV; Strokova TV; Gundobina OS; Zakharova EY
Mol Genet Metab; 2019 Jul; 127(3):212-215. PubMed ID: 31230978
[TBL] [Abstract][Full Text] [Related]
11. Wolman Disease: A Mimic of Infant Leukemia.
Gopakumar KG; Thankamony P; Nampoothiri S; Bali D; Raj J; A Vasudevan J; K Nair R
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e489-e492. PubMed ID: 28538091
[TBL] [Abstract][Full Text] [Related]
12. Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency.
Santillán-Hernández Y; Almanza-Miranda E; Xin WW; Goss K; Vera-Loaiza A; Gorráez-de la Mora MT; Piña-Aguilar RE
World J Gastroenterol; 2015 Jan; 21(3):1001-8. PubMed ID: 25624737
[TBL] [Abstract][Full Text] [Related]
13. [Wolman disease with novel mutation of LIPA gene in a Chinese infant].
Huang YL; Sheng HY; Zhao XY; Yu JK; Li L; Liu HS; Gu CM; He DM; Liu L
Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):601-5. PubMed ID: 23158738
[TBL] [Abstract][Full Text] [Related]
14. Structural bases of Wolman disease and cholesteryl ester storage disease.
Saito S; Ohno K; Suzuki T; Sakuraba H
Mol Genet Metab; 2012 Feb; 105(2):244-8. PubMed ID: 22138108
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal Acid Lipase in Lipid Metabolism and Beyond.
Li F; Zhang H
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):850-856. PubMed ID: 30866656
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.
Anderson RA; Bryson GM; Parks JS
Mol Genet Metab; 1999 Nov; 68(3):333-45. PubMed ID: 10562460
[TBL] [Abstract][Full Text] [Related]
17. Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency.
Zhang B; Porto AF
J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):682-5. PubMed ID: 23403440
[TBL] [Abstract][Full Text] [Related]
18. Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
Civallero G; De Mari J; Bittar C; Burin M; Giugliani R
Gene; 2014 Apr; 539(1):154-6. PubMed ID: 24508470
[TBL] [Abstract][Full Text] [Related]
19. A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.
Ries S; Aslanidis C; Fehringer P; Carel JC; Gendrel D; Schmitz G
J Lipid Res; 1996 Aug; 37(8):1761-5. PubMed ID: 8864960
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of a mutation associated with Wolman disease in a family with cholesteryl ester storage disease.
Maslen CL; Babcock D; Illingworth DR
J Inherit Metab Dis; 1995; 18(5):620-3. PubMed ID: 8598644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
